Nebraska Administrative Code
Topic - HEALTH AND HUMAN SERVICES SYSTEM
Title 180 - CONTROL OF RADIATION
Chapter 7 - MEDICAL USE OF RADIOACTIVE MATERIAL
Section 180-7-051 - TRAINING FOR USE OF UNSEALED RADIOACTIVE MATERIAL FOR WHICH A WRITTEN DIRECTIVE IS REQUIRED

Universal Citation: 180 NE Admin Rules and Regs ch 7 ยง 051

Current through September 17, 2024

Other than as provided in 180 NAC 7-026, the licensee must require an authorized user of unsealed radioactive material for the uses authorized under 180 NAC 7-048 to be a physician who:

(A) Is certified by a medical specialty board whose certification process has been recognized by the Department, an Agreement State, or the NRC who meets the requirements in 180 NAC 7-051(B)(i)(2)(f) and 7-051(B)(ii). Specialty Boards whose certification process has been recognized by an Agreement State or the NRC are posted on the NRC's Medical Uses Licensee Toolkit website. To be recognized, a specialty board must require all candidates for certification to:

(i) Successfully complete residency training in a radiation therapy or nuclear medicine training program or a program in a related medical specialty. These residency training programs must include 700 hours of training and experience as described in 180 NAC 7-051(B)(i)(1) through 7-051(B)(i)(2)(e). Eligible training programs must be approved by the Residency Review Committee of the Accreditation Council for Graduate Medical Education or Royal College of Physicians and Surgeons of Canada or the Council on Postdoctoral Training of the American Osteopathic Association; and

(ii) Pass an examination, administered by diplomates of the specialty board, which tests knowledge and competence in radiation safety, radionuclide handling, quality assurance, and clinical use of unsealed radioactive material for which a written directive is required; or

(B) The physician has:

(i) Completed 700 hours of training and experience, including a minimum of 200 hours of classroom and laboratory training, in basic radionuclide handling techniques applicable to the medical use of unsealed radioactive material requiring a written directive. The training and experience must include:
(1) Classroom and laboratory training in the following areas:
(a) Radiation physics and instrumentation;

(b) Radiation protection;

(c) Mathematics pertaining to the use and measurement of radioactivity;

(d) Chemistry of radioactive material for medical use; and

(e) Radiation biology; and

(2) Work experience, under the supervision of an authorized user who meets the requirements in 180 NAC 7-026, 7-051, or equivalent NRC or Agreement State requirements. A supervising authorized user, who meets the requirements in 180 NAC 7-051(B), must also have experience in administering dosages in the same dosage category or categories, 180 NAC 7-051(B)(i)(2)(f), as the individual requesting authorized user status. The work experience must involve:
(a) Ordering, receiving, and unpacking radioactive materials safely and performing the related radiation surveys;

(b) Performing quality control procedures on instruments used to determine the activity of dosages, and performing checks for proper operation of survey meters;

(c) Calculating, measuring, and safely preparing patient or human research subject dosages;

(d) Using administrative controls to prevent a misadministration involving the use of unsealed radioactive material;

(e) Using procedures to contain spilled radioactive material safely and using proper decontamination procedures; and

(f) Administering dosages of radioactive drugs to patients or human research subjects in each of the following categories. Radioactive drugs containing radionuclides in categories not included in this paragraph are regulated under 180 NAC 7-085. This work experience must involve a minimum of three cases in each of the following categories for which the individual is requesting authorized user status:
(i) Oral administration of less than or equal to 1.22 GBq (33 mCi) of sodium iodide I-131, for which a written directive is required;

(ii) Oral administration of greater than 1.22 GBq (33 mCi) of sodium iodide I-131. Experience with at least three cases in 180 NAC 7-051(B)(i)(2)(f)(ii) also satisfies the requirement in 180 NAC 7-051(B)(i)(2)(f)(i); and

(iii) Parenteral administration of any radioactive drug that contains a radionuclide primarily used for its electron emission, beta radiation characteristics, alpha radiation characteristics, or photon energy of less than 150 keV, for which a written directive is required; and

(ii) Obtained written attestation that the individual has satisfactorily completed the requirements in 180 NAC 7-051(B) and is able to independently fulfill the radiation safety-related duties as an authorized user for the medical uses authorized under 180 NAC 7-048 for which the individual is requesting authorized user status. The attestation must be obtained from either:
(1) A preceptor authorized user who meets the requirements in 180 NAC 7-026 or 7-051, or equivalent NRC or Agreement State requirements, and has experience in administering dosages in the same dosage category or categories as the individual requesting authorized user status; or

(2) A residency program director who affirms in writing that the attestation represents the consensus of the residency program faculty where at least one faculty member is an authorized user who meets the requirements in 180 NAC 7-026 or 7-051, or equivalent NRC or Agreement State requirements, has experience in administering dosages in the same dosage category or categories as the individual requesting authorized user status, and concurs with the attestation provided by the residency program director. The residency training program must be approved by the Residency Review Committee of the Accreditation Council for Graduate Medical Education or the Royal College of Physicians and Surgeons of Canada or the Council on Postdoctoral Training of the American Osteopathic Association and must include training and experience specified in 180 NAC 7-051(B).

Disclaimer: These regulations may not be the most recent version. Nebraska may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.